OTCM
TDNT
Market cap11kUSD
Sep 22, Last price
0.00USD
Name
Trident Brands Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Trident Brands Incorporated, operating through its subsidiaries, is dedicated to developing and bringing to market proprietary consumer products and raw materials. Its efforts are concentrated within the nutritional supplement, life sciences, and food and beverage sectors, targeting markets across both the United States and Canada. A prominent offering in its portfolio is a range of DHA dietary supplements, distributed under the "Brain Armor" label. Beyond its product lines, the company maintains diverse financial arrangements and holds essential regulatory licenses for the production, importation, and sale of natural health and wellness products. Initially established in 2007 as Sandfield Ventures Corp., the entity rebranded to Trident Brands Incorporated in July 2013. Its corporate headquarters are situated in Boca Raton, Florida.
Key people
Anthony M. Pallante
Chairman of the Board, Chief Executive Officer · since 2016
Scott Chapman
President, Director · since 2019
Donald MacPhee
Director of Operations · since 2016
Peter Salvo
Controller, Secretary · since 2016
Michael Browne
Brand Director · since 2017
Mark R. Holcombe
Director · since 2019
Headquarters & legal address
C/O Resident Agents of Nevada, Inc.
711 South Carson Street
Suite 4
Carson City, NV 89701
US
711 South Carson Street
Suite 4
Carson City, NV 89701
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2022‑11 | 2021‑11 | 2020‑11 | 2019‑11 | 2018‑11 | 2017‑11 | 2016‑11 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||